Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-06-12
2007-06-12
Switzer, Juliet C. (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091200
Reexamination Certificate
active
09692077
ABSTRACT:
The present invention includes polymorphisms in nucleic acids encoding the alpha-2B adrenergic receptor and expressed alpha-2B adrenergic receptor molecule. The invention also pertains to methods and molecules for detecting such polymorphisms. The invention further pertains to the use of such molecules and methods in the diagnosis, prognosis, and treatment of diseases such as cardiovascular and central nervous system diseases.
REFERENCES:
patent: 5595880 (1997-01-01), Weinshank et al.
patent: 5648482 (1997-07-01), Meyer
patent: 5846710 (1998-12-01), Bajaj
patent: 5856092 (1999-01-01), Dale et al.
patent: 5888819 (1999-03-01), Goelet et al.
patent: 5981174 (1999-11-01), Wolf et al.
patent: 6004744 (1999-12-01), Goelet et al.
patent: 6013431 (2000-01-01), Soderlund et al.
patent: 6156503 (2000-12-01), Drazen et al.
patent: 6566101 (2003-05-01), Shuber et al.
patent: 2001/0016338 (2001-08-01), Snapir et al.
patent: WO 0129082 (2001-04-01), None
Newton, C.R. Chapter 6: Primers, in PCR Essential Data, C.R. Newton, ed., John Wiley & Sons, Chichester, 1995, pp. 49-56.
Ho et al. (American Journal of Medical Genetics, vol. 81, No. 6, p. 510, Abstract #93).
Salonen et al. (Circulation, Oct. 2000, vol. 102, No. 18, Supplement, p. 859, abstract #4125).
Pollin et al. Obesity Research, Oct. 2000, vol. 8, Supplement 1p. 113S, abstract PE4.
Limbird, L. E. (1988) FASEB J 2, 2686-2695.
Eason, M. G. and Liggett, S. B. (1993) Mol.Pharmacol. 44, 70-75.
Handy, D. E., Flordellis, C. S., Bogdanova, N. N., Bresnahan, M. R., and Gavras, H. (1993) Hypertension 21, 861-865.
Tavares, A., Handy, D. E., Bogdanova, N. N., Rosene, D. L., and Gavras, H. (1996) Hypertension 27, 449-455.
Hein, L., Limbird, L. E., Eglen, R. M., and Kobilka, B. K. (1999) Ann NY Acad Sci 881, 265-271.
Rohrer, D. K. and Kobilka, B. K. (1998) Physiol Rev 78, 35-52.
Ruffolo, R. R., Jr., Nichols, A. J., Stadel, J. M., and Hieble, J. P. (1993) Annu Rev Pharmacol Toxicol 32, 243-279.
Sallinen, J., Haapalinna, A., Viitamaa, T., Kobilka, B. K., and Scheinin, M. (1998) The Journal of Neuroscience 18, 3035-3042.
Sallinen, J., Haapalinna, A., Macdonald, E., Viitamaa, T., Lahdesmaki, J., Rybnikova, E., Pelto-Huikko, M., Kobilka, B. K., and Scheinin, M. (1999) Mol Psychiatry 4, 443-452.
Altman, J. D., Trendelenburg, A. U., MacMillan, L., Bernstein, D., Limbird, L., Starke, K., Kobilka, B. K., and Hein, L. (1999) Mol.Pharmacol. 56, 154-161.
Hein, L., Altman, J. D., and Kobilka, B. K. (1999) Nature 402, 181-184.
Link, R. E., Desai, K., Hein, L., Stevens, M. E., Chruscinski, A., Bernstein, D., Barsh, G. S., and Kobilka, B. K. (1996) Science 273, 803-805.
Makaritsis, K. P., Handy, D. E., Johns, C., Kobilka, B., Gavras, I., and Gavras, H. (1999) Hypertension 33, 14-17.
Liggett, S. B., Ostrowski, J., Chestnut, L. C., Kurose, H., Raymond, J. R., Caron, M. G., and Lefkowitz, R. J. (1992) J.Biol.Chem. 267, 4740-4746.
Eason, M. G., Moreira, S. P., and Liggett, S. B. (1995) J.Biol.Chem. 270, 4681-4688.
Eason, M. G. and Liggett, S. B. (1992) J.Biol.Chem. 267, 25473-25479.
Jewell-Motz, E. A. and Liggett, S. B. (1995) Biochem 34, 11946-11953.
Kurose, H. and Lefkowitz, R. J. (1994) J.Biol.Chem. 269, 10093-10099.
Pitcher, J. A., Freedman, N. J., and Lefkowitz, R. J. (1998) Annu Rev Biochem 67, 692.
Heinonen, P., Koulu, M., Pesonen, U., Karvonen, M. K., Rissanen, A., Laakso, M., Valve, R., Uusitupa, M., and Scheinin, M. (1999) J Clin Endocrinol Metab 84, 2429-2433.
Baldwin, C. T., Schwartz, F., Baima, J., Burzstyn, M., DeStefano, A. L., Gavras, I., Handy, D. E., Joost, O., Martel, T., Manolis, A., Nicolaou, M., Bresnahan, M., Farrer, L., and Gavras, H. (1999) Am J Hypertens 12, 853-857.
Eason, M. G., Jacinto, M. T., and Liggett, S. B. (1994) Mol.Pharmacol. 45, 696-702.
Jewell-Motz, E. A., Small, K. M., and Liggett, S. B. (2000) J.Biol.Chem.
Small, K. M., Forbes, S. L., Rahman, F. F., Bridges, K. M., and Liggett, S. B. (2000) J.Biol.Chem. 275, 23059-23064.
Hausdorff, W. P., Bouvier, M., O'Dowd, B. F., Irons, G. P., Caron, M. G., and Lefkowitz, R. J. (1989) J.Biol.Chem. 264, 12657-12665.
Baron, B. M. and Siegel, B. W. (1990) Mol Pharmacol 38, 348-356.
Smith, P. K., Krohn, R. I., Hermanson, G. T., Mallia, A. K., Gartner, F. H., Provenzano, M. D., Fujimoto, E. K., Goeke, N. M., Olson, B. J., and Klenk, D. C. (1985) Anal.Biochem. 150, 76-85.
Onorato, J. J., Palczewski, K., Regan, J. W., Caron, M. G., Lefkowitz, R. J., and Benovic, J. L. (1991) Biochem 30, 5118-5125.
Jewell-Motz, E. A. and Liggett, S. B. (1996) J.Biol.Chem. 271, 18082-18087.
MacMillan, L. B., Hein, L., Smith, M. S., Piascik, M. T., and Limbird, L. E. (1996) Science 273, 801-805.
Munroe, P. B. and Caulfield, M. J. (2000) Curr Opin Genet Dev 10, 325-329.
“Introduction to α-adrenoceptors,” http://www.adrenoceptor.com/alphaintro.htm (Website visited Apr. 2, 2001), (author, vol., pp.-N/A).
Robinson, E. & Hudson, A. “Adrenoceptor Pharmacology,” http://www.tocris.com/adrenoceptor.htm, Nov. 1998 (Website visited Mar. 19, 2001), (vol., pp.-N/A).
Heinonen P. et al: “Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects.”The Journal of Clinical Endocrinology and Metabolism, United States, Jul. 1999, vol. 84, No. 7, pp. 2429-2433.
Baldwin C.T., et al: “Identification of a polymorphic glutamic acid stretch in the alpha2B-adrenergic receptor and lack of linkage with essential hypertension.”American Journal of Hypertension: Journal of the American Society of Hypertension, United States, Sep. 1999, vol. 12, No. 9, Pt. 1, pp. 853-857.
Jewell-Motz, E.A. et al: “An acidic motif within the third intracellular loop of the alpha2C2 adrenergic receptor is required for agonist-promoted phosphorylation and desensitization.”Biochemistry, United States Sep. 19, 1995, vol. 34, No. 37, Sep. 19, 1995, pp. 11946-11953.
Comings, D.E., et al: “Additive effect of three noradrenergic genes (ADRA2a, ADRA2C, DBH) on attention-deficit hyperactivity disorder and learning disabilities in Tourette syndrome subjects.”Clinical Genetics, Denmark, Mar. 1999, vol. 55, No. 3, pp. 160-172.
Makaritsis K.P., et al: “Role of the alpha2B-adrenergic receptor in the development of salt-induced hypertension.”Hypertension. United States, Jan. 1999, vol. 33, No. 1, Jan. 1999, pp. 14-17.
Michel M.C., et al: “Functional correlates of alpha(2A)-adrenoceptor gene polymorphism in the HANE study.”Nephrology, Dialysis. Transplantation: Official Publication of the European Dialysis and Transplant Association-European Renal Association. England, Nov. 1999, vol. 14, No. 11, pp. 2657-2663.
Freeman K., et al: “Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans.”American Journal of Hypertension: Journal of the American Society of Hypertension. United States, Sep. 1995, vol. 8, No. 9, pp. 863-869.
Small K.M., et al: “Polymorphic deletion of three intracellular acidic residues of the alpha 2B-adrenergic receptor decreases G protein-coupled receptor kinase-mediated phosphorylation and desensitization.”The Journal of Biological Chemistry. United States, Feb. 16, 2001, vol. 276, No. 7, pp. 4917-4922.
Snapir A., et al: “An insertion/deletion polymorphism in the alpha2B-adrenergic receptor gene is a novel genetic risk factor for acute coronary events.”Journal of the American College of Cardiology. United States, May 2001, vol. 37, No. 6, pp. 1516-1522.
Liggett Stephen B.
Small Kersten M.
Fenwick & West LLP
Switzer Juliet C.
University of Cincinnati
LandOfFree
Alpha-2B-adrenergic receptor polymorphisms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Alpha-2B-adrenergic receptor polymorphisms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Alpha-2B-adrenergic receptor polymorphisms will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3847005